Main Article Content


Skin cancer is one of the leading causes of cancer-related deaths worldwide. It is estimated that by 2030, there will be around 13.1million deaths can occur due to skin cancer. Current treatment of skin cancer includes surgery, radiation and chemotherapy. Chemo-resistance, off-target effects and poor bioavailability are the major challenges for currently available drugs for the treatment of skin cancer. Transfersomes is a novel, elastic vesicular drug carrier composed of phospholipids, surfactants and ethanol for enhanced transdermal delivery. This article we have reviewed about merits/demerits, liposomes vs transfersomes, preparation methods, characterization, mechanism of skin delivery, and application and regulatory aspects of transfersomes in treating various skin cancers.


Skin cancer Melanoma Transfersomes Edge activator Topical and Transdermal

Article Details

How to Cite
Sivarajakumar Raahulan, Bharat Kumar Reddy Sanapalli, Sai Kiran SS. Pindiprolu, & Veera Venkata Satyanarayana Reddy Karri. (2019). Transfersome vs liposomes as drug delivery vehicle for the treatment of skin cancers. International Journal of Research in Pharmaceutical Sciences, 10(3), 1795-1807.